Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain assessment of adrenaline auto-injectors
2006-006264-27Phase 4Active
- Sponsor
- Medeca Pharma
- Start
- Jan 2007
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of epinephrine in atopic dermatitis (AD) (2 arms), sponsored by Medeca Pharma. Primary endpoint: Pain intensity after injection. Started Jan 2007; status: active.
02
Drugs
epinephrine
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2006-006264-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006264-27.